COMMUNIQUÉS West-GlobeNewswire

XENOVIEW® 3T coil passes Philips compatibility testing
01/12/2025
Polarean’s FDA cleared coil achieves important milestone, expanding clinical reach DURHAM, NC and LONDON, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX), a commercial-stage medical device leader in [...]
Kriya appoints Greg Di Russo, MD as Chief Medical Officer
01/12/2025
Accomplished biopharma executive with deep experience leading the development of complex biologics and gene therapies at multiple small and large biopharmaceutical companies RESEARCH TRIANGLE PARK, N.C., Dec. 01, 2025 ( [...]
MAIA Biotechnology Announces Open Market Purchases by CEO and Directors
01/12/2025
CHICAGO, Dec. 01, 2025 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, [...]
Centre For Neuro Skills Announces Grand Opening for New Plano Clinic; Fifth in Texas
01/12/2025
New 20,000+ square foot facility expands cutting-edge brain injury care in North Texas PLANO, Texas, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Centre for Neuro Skills (CNS) , a premier provider of treatment for traumatic and [...]
ALK appoints Edward Jordan as new EVP and head of Commercial Operations North America
01/12/2025
ALK (ALKB:DC / OMX: ALK B) today announced the appointment of Edward Jordan as new Executive Vice President (EVP) and head of Commercial Operations in North America as per 5 January 2026. Edward Jordan succeeds Søren [...]
Evestia Clinical Announces New Strategic Advisory Board to Advance Specialist CRO Capabilities Worldwide
01/12/2025
New advisory board brings further world-class expertise in oncology, neurology, geographic market expansion, and AI enabled clinical trial delivery to support biotech innovators LETCHWORTH GARDEN CITY, United Kingdom, [...]
New Genome BC Funded Project Aims to Bring BC Closer to Ending HIV Transmission
01/12/2025
VANCOUVER, British Columbia, Dec. 01, 2025 (GLOBE NEWSWIRE) -- World AIDS Day 2025 — British Columbia has made remarkable progress in reducing HIV transmission and researchers now believe the province is closer than [...]
€150 million agreement between EIB and Angelini Ventures to finance European startups
01/12/2025
This is the first agreement signed by the EIB with a corporate venture capital in the healthcare sector, and is part of the EU strategy to support the development of innovative companies across the continent. Angelini [...]
REMINDER: Zealand Pharma’s Capital Markets Day on December 11, 2025
01/12/2025
Press release – No. 17 / 2025 REMINDER: Zealand Pharma’s Capital Markets Day on December 11, 2025 Copenhagen, Denmark, December 1, 2025 - Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company [...]
BioNTX Concludes Landmark iC³® 2025 Summit — Announces 2026 Summit in Arlington, Texas
01/12/2025
DALLAS, Dec. 01, 2025 (GLOBE NEWSWIRE) -- The 2025 iC³® Life Science & Healthcare Innovation Summit, hosted by BioNTX , concluded on September 16–17 at the Hilton Anatole in Dallas, marking more than a decade of [...]
Hapbee Delivers Record Profit of USD $1.43 Million in Second Straight Quarter of Growth, Posts Q3 Revenue of $446,897 and Earnings of 0.5 Cents Per Share
01/12/2025
Record-setting financial performance driven by new management team grows recurring revenue position with 188% subscriber growth since Q1, reducing liabilities while advancing investments into Hapbee’s next-generation [...]
Longeveron New MRI Biomarker Data Linking Neuroinflammation to Clinical Outcomes in Patients with Mild Alzheimer’s Disease Presented at the Clinical Trials on Alzheimer’s Disease Conference (CTAD 2025)
01/12/2025
Results obtained in the Phase 2 placebo-controlled CLEAR-MIND clinical trial showed that treatment with stem cell therapy laromestrocel was associated with a reduction in MRI measured neuroinflammation compared to [...]
Plus Therapeutics to Present ReSPECT Phase 1 Dose Escalation Study Results for Leptomeningeal Metastases at the 2025 San Antonio Breast Cancer Symposium
01/12/2025
Study findings to be featured in a poster spotlight presentation HOUSTON, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV ) (the “Company”), a clinical-stage pharmaceutical company developing [...]
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/12/2025
CLEVELAND, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in [...]
Biogen and Stoke Therapeutics Announce Presentations at the 2025 American Epilepsy Society Annual Meeting
01/12/2025
New analyses from the ongoing open label extension (OLE) studies and findings from electroencephalogram (EEG) assessments in patients with Dravet syndrome treated with zorevunersen support the potential for disease [...]
Altimmune Announces CEO Transition and Succession Plan
01/12/2025
Jerry Durso, accomplished industry leader, to succeed Vipin Garg, Ph.D. as Chief Executive Officer Transition follows seven years of strong leadership by Dr. Garg GAITHERSBURG, Md., Dec. 01, 2025 (GLOBE NEWSWIRE) -- [...]
ORIC® Pharmaceuticals Announces Enozertinib (ORIC-114) Poster Presentation in HER2 exon 20 NSCLC at the ESMO Asia Congress 2025
01/12/2025
Company to host a conference call and webcast on Saturday, December 6, 2025, at 8:00 pm ET SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Dec. 01, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a [...]
Tectonic Therapeutic to Participate in December Investor Conferences
01/12/2025
WATERTOWN, Mass., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Tectonic Therapeutic , Inc. (NASDAQ: TECX) (“Tectonic”), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and [...]
BioNexus Gene Lab Corp. (Nasdaq: BGLC) and Fidelion Diagnostics Execute Exclusive Southeast Asia License for VitaGuard™ MRD Platform as Part of Strategic Alliance with Tongshu Gene
01/12/2025
KUALA LUMPUR, Malaysia and SINGAPORE, Dec. 01, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (“BGLC”) today announced that it has executed an Exclusive Intellectual Property License Agreement for Southeast Asia with [...]

Pages